
Simone Krebs
, Associate Professor, Nuclear Medicine · University of Texas M D Anderson Cancer Center
Credentials: · · · · ·
History
- 2014–2017
Nuclear Medicine
- 2002–2006
Doctor of Medicine
Research
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Journal of Clinical Investigation · 2016 · 595 citations
Molecular Therapy · 2013 · 328 citations
Journal of Nuclear Medicine · 2014 · 203 citations

20 papers

8 papers

8 papers
- SL
8 papers
- MD
6 papers

6 papers
- WW
6 papers

5 papers
Grants
- 2021–2028
Interrogating the in vivo Pharmacokinetics of Armored CARs with Radiohapten Capture
National Cancer Institute · R37
Contact PI · $3.4M · University of Tx Md Anderson Can Ctr
- 2025–2027
IL13Ra2-Targeted Radioimmunotherapy for Glioblastoma
National Cancer Institute · R21
Contact PI · $432.1K · University of Tx Md Anderson Can Ctr
Clinical trials
- 2025–2032
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
Principal investigator · Recruiting · Phase 1
M.D. Anderson Cancer Center
- 2022–2027
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
Principal investigator · Active not recruiting · Phase 1
M.D. Anderson Cancer Center
- 2021–2025
Glutamine PET Imaging Colorectal Cancer
Principal investigator · Terminated · Phase 1
M.D. Anderson Cancer Center
